Investment Strategy

Dr. Barzilay is the executive chairman of Genome Compiler Corporation, the leading vendor of a software platform for Synthetic Biology. Earlier, he was the interim CEO of CollaBrx, a biotechnology company which helped oncologists develop customized therapies for cancer patients. Dr. Barzilay was a General Partner with Walden International, a global Venture Capital firm. At Walden Dr. Barzilay led several investments in innovative software companies and served on their boards. Prior to joining Walden Dr. Barzilay was a co-founder, chairman, and CEO of Mergent Systems, a business-to-business e-commerce infrastructure start-up. Prior to Mergent, Dr. Barzilay held a variety of senior management positions in the software industry and was an AI researcher at Xerox Parc. Dr. Barzilay has an engineering degree from the Technion in Israel and an M.B.A. and Ph.D. degree from the University of Pittsburgh.

Ogen Perry is a portfolio manager at Persistix Compass Management which he co-founded in 2012. Compass is a conservative hedge fund which seeks to deliver equity level returns with the volatility more traditionally associated with highly rated fixed income investments.
Mr. Perry has over 20 years of experience in finance, venture capital and valuation. Mr Perry's professional experience includes Managing Director and head of Valuation practice at Pagemill Partners, LLC, Partner at Vertex Venture Capital Israel, Founder of California Israel Angels, Partner at Helix Capital, Investment Manager at Intel Capital, and Engagement Manager at McKinsey & Co.
Mr. Perry holds an MBA with Distinction from the Wharton School at the University of Pennsylvania as well as a BE and a ME in Computer Engineering from Rensselaer Polytechnic Institute.

Zvi Eintracht is an innovator who built several ground breaking technology companies over the years. With ScanVec he developed the revolutionary raster-to-vector technology and an all-in-one, device independent graphics design and production platform that catapulted ScanVec to dominating the signage making industry for the past 20 years. With Real Time Image he introduced high-quality on-demand wavelet based image-streaming, and brought remote medical image review to the healthcare world, and remote collaboration in print design and production to the advertising world and the pre-press & print-production business. After considerable success over the years – including taking ScanVec public on Nasdaq in 1995, selling Real Time Image print business to Kodak in 2003, and the healthcare business to IDX (GE Medical Systems) in 2005, Zvi – who specializes in signal processing and holds Masters degree in electrical engineering - shifted his research efforts to quantitative finance.
Onshore Capital, a market-neutral hedge fund that Zvi created in 2012 aims to protect against market calamity by shorting the market for a full hedge at all times, and yet also deliver high returns by uncovering and exploiting short-term pricing inefficiencies of individual equities. In 2013 Onshore Capital achieved return of 24% net after fees, placing its performance at #4 globally among market-neutral hedge funds for the year according to the Barclay Hedge funds database.